NCT06940427View on ClinicalTrials.gov

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Fibrosis Lung
Interventions
DRUG

FAPI tracer

"radioactive substance called a tracer injected into the arm"

DEVICE

PET/MRI

positron emission tomography (PET) takes pictures of inside of the body

Trial Locations (1)

53705

University of Wisconsin - Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER